State-of-the-Art Research on C1q and the Classical Complement Pathway

C1q is the target recognition protein of the classical complement pathway and a major connecting link between innate and acquired immunity. As a charge pattern recognition molecule of innate immunity, C1q can engage a broad range of ligands derived from self, non-self and altered self via its hetero...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Christine Gaboriaud, Nicole M. Thielens, Uday Kishore
Μορφή: Online
Γλώσσα:Αγγλικά
Έκδοση: Frontiers Media SA 2021
Θέματα:
Διαθέσιμο Online:25556
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
_version_ 1869529523051036672
author Christine Gaboriaud
Nicole M. Thielens
Uday Kishore
author_browse Christine Gaboriaud
Nicole M. Thielens
Uday Kishore
author_facet Christine Gaboriaud
Nicole M. Thielens
Uday Kishore
author_sort Christine Gaboriaud
collection Directory of Open Access Books
description C1q is the target recognition protein of the classical complement pathway and a major connecting link between innate and acquired immunity. As a charge pattern recognition molecule of innate immunity, C1q can engage a broad range of ligands derived from self, non-self and altered self via its heterotrimeric globular (gC1q) domain and thus trigger the classical complement pathway. The trimeric gC1q signature domain has been identified in a variety of non-complement proteins that can be grouped together as a C1q family. C1q circulates in serum as part of the C1 complex, in association with a catalytic tetrameric assembly of two homologous yet distinct serine proteases, C1r and C1s. Binding of C1q to appropriate targets leads to sequential activation of C1r and C1s, the latter being able to cleave complement components C4 and C2 thereby triggering the complement cascade. Activation of the classical pathway plays an important role in innate immune protection against pathogens and damaged elements from self. However, its involvement has been shown in various pathologies including ischemia-reperfusion injury and hereditary angioedema. Unexpected roles for the classical pathway have also been discovered recently, linked to both physiological and pathological aspects of development, including brain and cancer cells. These new perspectives should arouse renewed interest in a search for specific inhibitors of the classical pathway. In addition, C1q has recently been shown to have a number of functions that are independent of the activation of the classical pathway. This research topic is aimed at providing a state-of-the-art overview of the classical pathway, including, but not restricted to emerging functions of C1q and of the C1 complex, as well as pathological consequences of C1 activation or of the presence of anti-C1q autoantibodies . Contributions are included in the areas such as structural basis of C1q ligand recognition, C1q family proteins, inhibitors of the classical pathway identified in pathogens and improved derived inhibitors, structural determinants of the substrate specificities of C1r and C1s, elucidation of the architecture of C1, structural and functional homology of C1 with the initiating complexes of the lectin complement pathway, and novel involvement of C1q in processes such as ageing, cancer, synaptic pruning, and pregnancy.
format Online
id doab-20.500.12854ir-59991
institution Directory of Open Access Books
language eng
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher Frontiers Media SA
publisherStr Frontiers Media SA
record_format ojs
spelling doab-20.500.12854ir-599912024-03-31T13:10:08Z State-of-the-Art Research on C1q and the Classical Complement Pathway Christine Gaboriaud Nicole M. Thielens Uday Kishore R5-920 RC581-607 C1 complex classical pathway activation Autoimmunity c1q C1s emerging functions gC1q structure complement thema EDItEUR::M Medicine and Nursing C1q is the target recognition protein of the classical complement pathway and a major connecting link between innate and acquired immunity. As a charge pattern recognition molecule of innate immunity, C1q can engage a broad range of ligands derived from self, non-self and altered self via its heterotrimeric globular (gC1q) domain and thus trigger the classical complement pathway. The trimeric gC1q signature domain has been identified in a variety of non-complement proteins that can be grouped together as a C1q family. C1q circulates in serum as part of the C1 complex, in association with a catalytic tetrameric assembly of two homologous yet distinct serine proteases, C1r and C1s. Binding of C1q to appropriate targets leads to sequential activation of C1r and C1s, the latter being able to cleave complement components C4 and C2 thereby triggering the complement cascade. Activation of the classical pathway plays an important role in innate immune protection against pathogens and damaged elements from self. However, its involvement has been shown in various pathologies including ischemia-reperfusion injury and hereditary angioedema. Unexpected roles for the classical pathway have also been discovered recently, linked to both physiological and pathological aspects of development, including brain and cancer cells. These new perspectives should arouse renewed interest in a search for specific inhibitors of the classical pathway. In addition, C1q has recently been shown to have a number of functions that are independent of the activation of the classical pathway. This research topic is aimed at providing a state-of-the-art overview of the classical pathway, including, but not restricted to emerging functions of C1q and of the C1 complex, as well as pathological consequences of C1 activation or of the presence of anti-C1q autoantibodies . Contributions are included in the areas such as structural basis of C1q ligand recognition, C1q family proteins, inhibitors of the classical pathway identified in pathogens and improved derived inhibitors, structural determinants of the substrate specificities of C1r and C1s, elucidation of the architecture of C1, structural and functional homology of C1 with the initiating complexes of the lectin complement pathway, and novel involvement of C1q in processes such as ageing, cancer, synaptic pruning, and pregnancy. 2021-02-12T04:30:30Z 2021-02-12T04:30:30Z 2018-02-27 16:16:44 2016 book 25556 16648714 9782889450589 https://directory.doabooks.org/handle/20.500.12854/59991 eng Frontiers Research Topics image/jpeg Attribution 4.0 International http://www.frontiersin.org/books/State-of-the-Art_Research_on_C1q_and_the_Classical_Complement_Pathway/1067#nogo http://journal.frontiersin.org/researchtopic/1324/state-of-the-art-research-on-c1q-and-the-classical-complement-pathway Frontiers Media SA 10.3389/978-2-88945-058-9 10.3389/978-2-88945-058-9 bf5ce210-e72e-4860-ba9b-c305640ff3ae 9782889450589 100 open access
spellingShingle R5-920
RC581-607
C1 complex
classical pathway activation
Autoimmunity
c1q
C1s
emerging functions
gC1q structure
complement
thema EDItEUR::M Medicine and Nursing
Christine Gaboriaud
Nicole M. Thielens
Uday Kishore
State-of-the-Art Research on C1q and the Classical Complement Pathway
title State-of-the-Art Research on C1q and the Classical Complement Pathway
title_full State-of-the-Art Research on C1q and the Classical Complement Pathway
title_fullStr State-of-the-Art Research on C1q and the Classical Complement Pathway
title_full_unstemmed State-of-the-Art Research on C1q and the Classical Complement Pathway
title_short State-of-the-Art Research on C1q and the Classical Complement Pathway
title_sort state of the art research on c1q and the classical complement pathway
topic R5-920
RC581-607
C1 complex
classical pathway activation
Autoimmunity
c1q
C1s
emerging functions
gC1q structure
complement
thema EDItEUR::M Medicine and Nursing
topic_facet R5-920
RC581-607
C1 complex
classical pathway activation
Autoimmunity
c1q
C1s
emerging functions
gC1q structure
complement
thema EDItEUR::M Medicine and Nursing
url 25556
work_keys_str_mv AT christinegaboriaud stateoftheartresearchonc1qandtheclassicalcomplementpathway
AT nicolemthielens stateoftheartresearchonc1qandtheclassicalcomplementpathway
AT udaykishore stateoftheartresearchonc1qandtheclassicalcomplementpathway